InsiderTrades

Form 4 for IMAX IMAX CORP

Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-14 · accession 0001214659-25-012287 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-14 2025-08-14 IMAX Weissman Kenneth Ian CCO, Deputy GC, Corp. Sec S - Sale $25.65 -15.1K 34.1K -31% -$386.6K
D 2025-08-14 2025-08-14 IMAX Weissman Kenneth Ian CCO, Deputy GC, Corp. Sec C - Cnv Deriv $22.49 +7,072 41.2K +21% +$159.0K
D 2025-08-14 2025-08-14 IMAX Weissman Kenneth Ian CCO, Deputy GC, Corp. Sec C - Cnv Deriv $22.49 -7,072 0 -100% -$159.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common common shares 2025-08-14 S D 8,000 $25.63 26,133 D — —
2 Common common shares 2025-08-14 C A 7,072 $22.49 41,205 D — — (F1) Represents the conversion upon exercise of stock options into common shares.
3 Common common shares 2025-08-14 S D 7,072 $25.67 34,133 D — —
4 Derivative stock options (to buy) 2025-08-14 C D 7,072 $22.49 0 D $22.49 · — to 2026-03-07 7,072 common shares (F2) These options were issued in 2019 and are set to expire on March 7, 2026. (F4) This represents the number of restricted share units for this transaction only. Mr. Weissman's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 17,021 and 26,133. respectively. (F3) The stock options became exercisable in four installments: 1,414 on March 7, 2020, 1,768 on each of March 7, 2021 and March 7, 2022, and 2,122 on March 7, 2023.